Stent coronarico a rilascio di farmaco (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Stent coronarico a rilascio di farmaco" in Italian language version.

refsWebsite

Global rank Italian rank

10doi.org

2^nd place

7^th place

9oadoi.org

799^th place

22^nd place

9nih.gov

4^th place

9^th place

1nejm.org

2,374^th place

1,283^rd place

1salute.gov.it

low place

615^th place

1web.archive.org

1^st place

1scielo.br

1,606^th place

2,745^th place

doi.org

dx.doi.org

Moses JW, Leon MB, Popma JJ, et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, in N. Engl. J. Med., vol. 349, n. 14, ottobre 2003, pp. 1315–23, DOI:10.1056/NEJMoa035071, PMID 14523139.
Stone GW, Ellis SG, Cox DA, et al., One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial, in Circulation, vol. 109, n. 16, aprile 2004, pp. 1942–7, DOI:10.1161/01.CIR.0000127110.49192.72, PMID 15078803.
(EN) Jeffrey L. Anderson e David A. Morrow, Acute Myocardial Infarction, in New England Journal of Medicine, vol. 376, n. 21, 24 maggio 2017, pp. 2053–2064, DOI:10.1056/nejmra1606915. URL consultato il 9 dicembre 2017.
(EN) Glenn N. Levine, Eric R. Bates e John A. Bittl, 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease, in Journal of the American College of Cardiology, vol. 68, n. 10, pp. 1082–1115, DOI:10.1016/j.jacc.2016.03.513. URL consultato il 10 dicembre 2017.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 24 giugno 2014.
Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP, Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease, in JACC Cardiovasc Interv, vol. 6, n. 4, aprile 2013, pp. 344–54, DOI:10.1016/j.jcin.2012.11.010, PMID 23523456. URL consultato il 24 giugno 2014.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 25 giugno 2014.
Ayça B, Akın F, Celik O, Cetin S, Sahin I, Gülşen K, Kalyoncuoğlu M, Katkat F, Okuyan E, Dinçkal MH, Whether Syntax Score predicts ın hospital outcomes in patients with ST elevation myocard ınfarction undergoing primary percutaneous coronary ıntervention, in Kardiol Pol, marzo 2014, DOI:10.5603/KP.a2014.0064, PMID 24671913. URL consultato il 25 giugno 2014.
Girasis C, Garg S, Räber L, Sarno G, Morel MA, Garcia-Garcia HM, Lüscher TF, Serruys PW, Windecker S, SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial, in Eur. Heart J., vol. 32, n. 24, dicembre 2011, pp. 3115–27, DOI:10.1093/eurheartj/ehr369, PMID 21951630. URL consultato il 25 giugno 2014.
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), in Eur. Heart J., vol. 32, n. 23, dicembre 2011, pp. 2999–3054, DOI:10.1093/eurheartj/ehr236, PMID 21873419. URL consultato il 24 giugno 2014.

nejm.org

(EN) Jeffrey L. Anderson e David A. Morrow, Acute Myocardial Infarction, in New England Journal of Medicine, vol. 376, n. 21, 24 maggio 2017, pp. 2053–2064, DOI:10.1056/nejmra1606915. URL consultato il 9 dicembre 2017.

nih.gov

ncbi.nlm.nih.gov

Moses JW, Leon MB, Popma JJ, et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, in N. Engl. J. Med., vol. 349, n. 14, ottobre 2003, pp. 1315–23, DOI:10.1056/NEJMoa035071, PMID 14523139.
Stone GW, Ellis SG, Cox DA, et al., One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial, in Circulation, vol. 109, n. 16, aprile 2004, pp. 1942–7, DOI:10.1161/01.CIR.0000127110.49192.72, PMID 15078803.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 24 giugno 2014.
Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP, Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease, in JACC Cardiovasc Interv, vol. 6, n. 4, aprile 2013, pp. 344–54, DOI:10.1016/j.jcin.2012.11.010, PMID 23523456. URL consultato il 24 giugno 2014.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 25 giugno 2014.
Ayça B, Akın F, Celik O, Cetin S, Sahin I, Gülşen K, Kalyoncuoğlu M, Katkat F, Okuyan E, Dinçkal MH, Whether Syntax Score predicts ın hospital outcomes in patients with ST elevation myocard ınfarction undergoing primary percutaneous coronary ıntervention, in Kardiol Pol, marzo 2014, DOI:10.5603/KP.a2014.0064, PMID 24671913. URL consultato il 25 giugno 2014.
Girasis C, Garg S, Räber L, Sarno G, Morel MA, Garcia-Garcia HM, Lüscher TF, Serruys PW, Windecker S, SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial, in Eur. Heart J., vol. 32, n. 24, dicembre 2011, pp. 3115–27, DOI:10.1093/eurheartj/ehr369, PMID 21951630. URL consultato il 25 giugno 2014.
Albuquerque LC, Lessons from the clinical trials FREEDOM and SYNTAX 5-years: new evidence or evidence only noticed now?, in Rev Bras Cir Cardiovasc, vol. 27, n. 4, dicembre 2012, pp. XII–XIV, PMID 23515746. URL consultato il 25 giugno 2014.
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), in Eur. Heart J., vol. 32, n. 23, dicembre 2011, pp. 2999–3054, DOI:10.1093/eurheartj/ehr236, PMID 21873419. URL consultato il 24 giugno 2014.

oadoi.org

Moses JW, Leon MB, Popma JJ, et al., Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, in N. Engl. J. Med., vol. 349, n. 14, ottobre 2003, pp. 1315–23, DOI:10.1056/NEJMoa035071, PMID 14523139.
Stone GW, Ellis SG, Cox DA, et al., One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial, in Circulation, vol. 109, n. 16, aprile 2004, pp. 1942–7, DOI:10.1161/01.CIR.0000127110.49192.72, PMID 15078803.
(EN) Glenn N. Levine, Eric R. Bates e John A. Bittl, 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease, in Journal of the American College of Cardiology, vol. 68, n. 10, pp. 1082–1115, DOI:10.1016/j.jacc.2016.03.513. URL consultato il 10 dicembre 2017.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 24 giugno 2014.
Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice MC, Unger F, Erglis A, Stoler R, Dawkins KD, Serruys PW, Mohr FW, Kappetein AP, Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease, in JACC Cardiovasc Interv, vol. 6, n. 4, aprile 2013, pp. 344–54, DOI:10.1016/j.jcin.2012.11.010, PMID 23523456. URL consultato il 24 giugno 2014.
Head SJ, Holmes DR, Mack MJ, Serruys PW, Mohr FW, Morice MC, Colombo A, Kappetein AP, Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries, in JACC Cardiovasc Interv, vol. 5, n. 6, giugno 2012, pp. 618–25, DOI:10.1016/j.jcin.2012.02.013, PMID 22721656. URL consultato il 25 giugno 2014.
Ayça B, Akın F, Celik O, Cetin S, Sahin I, Gülşen K, Kalyoncuoğlu M, Katkat F, Okuyan E, Dinçkal MH, Whether Syntax Score predicts ın hospital outcomes in patients with ST elevation myocard ınfarction undergoing primary percutaneous coronary ıntervention, in Kardiol Pol, marzo 2014, DOI:10.5603/KP.a2014.0064, PMID 24671913. URL consultato il 25 giugno 2014.
Girasis C, Garg S, Räber L, Sarno G, Morel MA, Garcia-Garcia HM, Lüscher TF, Serruys PW, Windecker S, SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial, in Eur. Heart J., vol. 32, n. 24, dicembre 2011, pp. 3115–27, DOI:10.1093/eurheartj/ehr369, PMID 21951630. URL consultato il 25 giugno 2014.
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), in Eur. Heart J., vol. 32, n. 23, dicembre 2011, pp. 2999–3054, DOI:10.1093/eurheartj/ehr236, PMID 21873419. URL consultato il 24 giugno 2014.

salute.gov.it

Stent coronarici a rilascio di farmaco Archiviato il 17 giugno 2012 in Internet Archive.

scielo.br

Albuquerque LC, Lessons from the clinical trials FREEDOM and SYNTAX 5-years: new evidence or evidence only noticed now?, in Rev Bras Cir Cardiovasc, vol. 27, n. 4, dicembre 2012, pp. XII–XIV, PMID 23515746. URL consultato il 25 giugno 2014.

web.archive.org

Stent coronarici a rilascio di farmaco Archiviato il 17 giugno 2012 in Internet Archive.